Applied Clinical Trials
A patient-centric approach to a Phase IV trial for an MS treatment resulted in lessons that can be applied to future therapeutic studies for this and other rare diseases.
Nancy Mulligan
Advertisement
Articles by Nancy Mulligan
Advertisement
Latest Updated Articles
Patient Centric MS Trial ResultsAugust 1st 2016
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
3
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
4
How AI Is Changing Endpoint Selection Before a Trial Even Starts
5